Correlation between In Vitro and In Vivo Antifungal Activities in Experimental Fluconazole-Resistant Oropharyngeal and Esophageal Candidiasis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (28)
Guide for the Care and Use of Laboratory Animals
2011 • 15,863 citations
Pharmacokinetics
1982 • 3,815 citations
Resistance of Candida species to fluconazole
1995 • 890 citations
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
1997 • 862 citations
Pharmacokinetics and Tissue Penetration of Fluconazole in Humans
1990 • 416 citations
Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistance
1994 • 321 citations
Resistance of Candida albicans to Fluconazole During Treatment of Oropharyngeal Candidiasis in a Patient with AIDS: Documentation by In Vitro Susceptibility Testing and DNA Subtype Analysis
1994 • 271 citations
Emergence of azole drug resistance in Candida species from HIV-infected patients receivingprolonged fluconazole therapy for oral candidosis
1995 • 257 citations
Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia
1997 • 227 citations
Risk Factors for Fluconazole-Resistant Candidiasis in Human Immunodeficiency Virus-Infected Patients
1996 • 154 citations
In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection
1997 • 128 citations
Chronic silastic central venous catheterization for induction, maintenance and support of persistent granulocytopenia in rabbits.
1988 • 124 citations
Correlation between In Vitro and In Vivo Activity of Antifungal Agents against Candida Species
1994 • 120 citations
Safety and pharmacokinetics of fluconazole in children with neoplastic diseases
1992 • 119 citations
Detection and Significance of Fluconazole Resistance in Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients
1996 • 111 citations
In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus
1994 • 90 citations
Pharmacokinetics and tissue penetration of fluconazole in rabbits
1989 • 73 citations
Tissue homogenization with sterile reinforced polyethylene bags for quantitative culture of Candida albicans
1987 • 58 citations
In vitrogrowth-inhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin B- and fluconazole-resistantCandidaisolates: influence of assay conditions
1997 • 53 citations
In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates
1996 • 34 citations
Susceptibility Testing of Fungi and Correlation with Clinical Outcome
1997 • 33 citations
Potential new antifungal agents
1997 • 30 citations
Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model
1996 • 29 citations
Histopathologic and immunohistochemical changes in gut-associated lymphoid tissues after treatment of rabbits with dexamethasone.
1992 • 29 citations
Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model
1996 • 27 citations
Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole
1995 • 27 citations
An animal model for the study of azidothymidine-induced hyperpigmentation.
1991 • 17 citations
ZD0870 treatment of murine candidiasis caused by fluconazole resistant isolates of Candida albicans
1996 • 6 citations